Statin Intensity and the Risk of Noninfectious Uveitis

Uveitis

Association of Statin Use and Non-Infectious Uveitis: A Systematic Review and Meta-Analysis

Ophthalmol Retina

Tao BK, Butt FR, Dhivagaran T, Mihalache A, Huang RS, Xie JS, Popovic MM, Kaplan AJ

doi: 10.1016/j.oret.2025.10.009

Retinal Diseases

Systemic Statin Use and Reduced Risk of Repeat Retinal Detachment Repair: A Retrospective Cohort Study

Ophthalmol Retina

Bantounou MA, Foteinou D, Baroutis KG, Emfietzoglou M, Bordbar DD, Brant AR, Miller JW, Vavvas DG

doi: 10.1016/j.oret.2026.06.024

Uveitis

Clinical Efficacy of Biosimilar Switch of Adalimumab and Infliximab for Noninfectious Uveitis: Systematic Review and Meta-analysis

Am J Ophthalmol

Zhang C, Ayoubi M, AbouKasm G, Ersan S, Zhu D, Wong A, Yannuzzi NA, Albini TA

doi: 10.1016/j.ajo.2025.11.015

UveitisFurther Publications

Human papillomavirus infection and the risk of uveitis: a propensity-score-matched electronic health record study

Sci Rep

Chang HC, Tu YF, Sung CY, Lin J, Lo SW, Su YJ, Chen SJ, Gau SY

doi: 10.1038/s41598-026-51328-x

Uveitis

Risk of non-infectious uveitis associated with disease-modifying therapies for multiple sclerosis

Am J Ophthalmol

Cordisco AJ, Jin F, Hamedani AG, VanderBeek BL

doi: 10.1016/j.ajo.2026.04.032

Glaucoma and Ocular PressureUveitis

Intraocular Pressure Elevation After Suprachoroidal Triamcinolone Acetonide in Noninfectious Uveitis: An IRIS® Registry Study

Ophthalmol Glaucoma

Nabavi A, Swaminathan SS, Davis JL, Medeiros FA, Yousefi S, IRIS® Registry Analytic Center Consortium

doi: 10.1016/j.ogla.2026.07.009

Uveitis

Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Non-infectious Uveitis

Ophthalmology

Chauhan MZ, Muayad J, Surgent-Nahay JL, Shakoor A, Thorne JE, Sallam AB

doi: 10.1016/j.ophtha.2026.06.030

Glaucoma and Ocular Pressure

Polygenic risk impacts lifetime risk and prognosis of glaucoma

Ophthalmology

Tusa ES, Tamlander M, Ripatti S, Harju M, Salo K, FinnGen, Turunen JA, Mars N

doi: 10.1016/j.ophtha.2026.06.003

Glaucoma and Ocular PressureUveitis

Real-World Incidence and Management of Ocular Hypertension Following Suprachoroidal Triamcinolone Acetonide Injection for Macular Edema in Noninfectious Uveitis

Retina

Hamdan SA, Zafar S, Nassur JA, Yonekawa Y, Kuriyan AE, Dunn JP, Cohen MN, Hsu J, Regillo CD, Garg SJ, Xu D, Klufas M, Deaner JD

doi: 10.1097/IAE.0000000000004677

Related content

Association of Statin Use and Non-Infectious Uveitis: A Systematic Review and Meta-Analysis

Systemic Statin Use and Reduced Risk of Repeat Retinal Detachment Repair: A Retrospective Cohort Study

Clinical Efficacy of Biosimilar Switch of Adalimumab and Infliximab for Noninfectious Uveitis: Systematic Review and Meta-analysis

Human papillomavirus infection and the risk of uveitis: a propensity-score-matched electronic health record study

Risk of non-infectious uveitis associated with disease-modifying therapies for multiple sclerosis

Intraocular Pressure Elevation After Suprachoroidal Triamcinolone Acetonide in Noninfectious Uveitis: An IRIS® Registry Study

Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Non-infectious Uveitis

Polygenic risk impacts lifetime risk and prognosis of glaucoma

Real-World Incidence and Management of Ocular Hypertension Following Suprachoroidal Triamcinolone Acetonide Injection for Macular Edema in Noninfectious Uveitis